NEUMORA THERAPEUTICS, INC. (NMRA) Operating cash flow 2022–2025
NEUMORA THERAPEUTICS, INC. (NMRA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$206.4MFY2025 · since FY2022: -$114.9M → -$206.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$206.4M | -12.8% |
| FY2024 | -$182.9M | -12.0% |
| FY2023 | -$163.3M | -42.1% |
| FY2022 | -$114.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice